Vaccinating against HPV: physicians' and medical students' point of view.
The present survey was conducted among medical students and physicians affiliated to the Federal University of Paraná, Curitiba, Brazil, between August 2006 and December 2007. 252 individuals responded to a questionnaire composed of 13 items regarding their individual status and their personal knowledge of the HPV vaccine properties. The data analysis that was carried out using chi-square test showed that 79.7% of the interviewed population would indicate the vaccine, and mostly, to girls aged 10-15 years old. While vaccine effectiveness and prophylaxis appeared to have been adequately understood, some of its properties such as safety and immunity duration still need further elucidation.
de Carvalho
Newton Sergio
NS
Department of Gynecology and Obstetrics, Federal University of Paraná, Infectious Diseases in Gynecology and Obstetrics Sector, Hospital de Clínicas, Curitiba, Brazil. infectogin@hotmail.com
Teixeira
Laila Meira
LM
Pradel
Elaine Maria
EM
Gabardo
Juarez
J
Joly
Cristina
C
Urbanetz
Almir Antonio
AA
D000328:Adult; D001938:Brazil; D005260:Female; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D008297:Male; D008875:Middle Aged; D030361:Papillomavirus Infections / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000009:adverse effects / Q000276:immunology*; D010820:Physicians; D013337:Students, Medical; D011795:Surveys and Questionnaires; D014495:Universities; D055815:Young Adult
D053918:Papillomavirus Vaccines